Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Elantas Beck India Limited (ELANTAS.BO)
Pune, MH, IN
ELANTAS Beck India Limited manufactures and sells specialty chemicals for the electrical insulation and construction industries in India. It operates through two segments, Electrical Insulations, and Engineering & Electronic Resins and Materials. The company provides wire enamels, such as primers, lubricants, and binder varnishes for fiberglass coated conductors; impregnating materials, including insulating varnishes and resins; and flexible electrical insulation materials. It also offers casting and potting compounds comprising casting, potting, and encapsulation of electrical and electronic components, such as auto-electrical components, high-voltage insulators, instrument transformers, etc.; impregnation of high-voltage electrical machine windings; binder resins for glass-fibre filament wound arc chamber tubes; and diamond dotted paper for oil-filled transformers. In addition, the company provides materials for electronic protection, including potting compounds, such as conformal, air drying resistant, rapid process acrylic, waterborne conformal, and silicone coatings; and thermal interface materials. Further, it offers engineering materials, such as construction chemicals comprising a range of resinous construction chemicals for industrial floorings, protective coatings, structural repairs, waterproofing, adhesives, and sealants, as well as specialty epoxy and polyurethane anti-microbial floorings and wall coating systems; and reactive polyamides used in epoxy resins to produce top coats and primers, as well as thermosetting adhesives for a various substrates. The company was incorporated in 1956 and is based in Pune, India. ELANTAS Beck India Limited is a subsidiary of Altana AG.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.53% | +0.41% | -4.22% | +2.71% | -5.10% | -3.71% | -5.16% | +57.58% | +148.16% | +508.34% | +14,474.15% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+13.3% ★ Q1'26: +7.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+5.9% Q1'26: -5.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+10.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+17.8% ★ Q1'26: +16.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+32.4% ★ Q1'26: +33.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3.44B
est: 3.80B (-9.4%)
|
3.64B
est: 3.69B (-1.4%)
|
3.81B
est: 3.73B (+2.1%)
|
4.09B
est: 4.17B (-2.0%)
|
3.93B
est: 4.11B (-4.5%)
|
3.82B
est: 4.52B (-15.5%)
|
7.49B
est: 3.80B (+97.0%)
|
8.48B
est: 3.69B (+129.5%)
|
3.73B
3.73B – 3.73B
+1.0% YoY
|
4.17B
4.17B – 4.17B
+11.8% YoY
|
4.11B
4.11B – 4.11B
-1.4% YoY
|
4.52B
4.52B – 4.52B
+10.0% YoY
|
| EBITDA |
676.77M
est: 918.82M (-26.3%)
|
860.78M
est: 893.23M (-3.6%)
|
866.78M
est: 901.95M (-3.9%)
|
766.52M
est: 1.01B (-24.0%)
|
710.64M
est: 994.56M (-28.5%)
|
920.49M
est: 1.09B (-15.9%)
|
1.98B
est: 878.90M (+125.7%)
|
1.72B
est: 854.42M (+101.5%)
|
862.76M
862.76M – 862.76M
+1.0% YoY
|
964.52M
964.52M – 964.52M
+11.8% YoY
|
951.35M
951.35M – 951.35M
-1.4% YoY
|
1.05B
1.05B – 1.05B
+10.0% YoY
|
| EBIT |
619.21M
est: 835.22M (-25.9%)
|
810.97M
est: 811.96M (-0.1%)
|
810.93M
est: 819.88M (-1.1%)
|
893.99M
est: 916.59M (-2.5%)
|
637.90M
est: 904.07M (-29.4%)
|
804.32M
est: 994.48M (-19.1%)
|
1.84B
est: 774.80M (+137.6%)
|
1.51B
est: 753.22M (+100.4%)
|
760.57M
760.57M – 760.57M
+1.0% YoY
|
850.28M
850.28M – 850.28M
+11.8% YoY
|
838.67M
838.67M – 838.67M
-1.4% YoY
|
922.54M
922.54M – 922.54M
+10.0% YoY
|
| Net Income |
417.56M
est: 338.43M (+23.4%)
|
544.88M
est: 562.94M (-3.2%)
|
550.82M
est: 552.56M (-0.3%)
|
657.85M
est: 601.47M (+9.4%)
|
495.61M
est: 551.53M (-10.1%)
|
617.64M
est: 620.02M (-0.4%)
|
1.40B
est: 338.45M (+312.4%)
|
1.48B
est: 562.97M (+162.5%)
|
552.58M
552.58M – 552.58M
-1.8% YoY
|
601.50M
601.50M – 601.50M
+8.9% YoY
|
551.55M
551.55M – 551.55M
-8.3% YoY
|
620.05M
620.05M – 620.05M
+12.4% YoY
|
| SGA |
144.73M
est: 195.93M (-26.1%)
|
33.21M
est: 190.47M (-82.6%)
|
46.15M
est: 192.33M (-76.0%)
|
41.13M
est: 215.01M (-80.9%)
|
76.73M
est: 212.08M (-63.8%)
|
283.03M
est: 233.29M (+21.3%)
|
243.54M
est: 224.83M (+8.3%)
|
949.92M
est: 218.57M (+334.6%)
|
220.71M
220.71M – 220.71M
+1.0% YoY
|
246.74M
246.74M – 246.74M
+11.8% YoY
|
243.37M
243.37M – 243.37M
-1.4% YoY
|
267.71M
267.71M – 267.71M
+10.0% YoY
|
| EPS |
52.67
est: 42.69 (+23.4%)
|
68.73
est: 71.01 (-3.2%)
|
69.48
est: 69.70 (-0.3%)
|
82.98
est: 75.87 (+9.4%)
|
62.52
est: 69.57 (-10.1%)
|
77.91
est: 78.21 (-0.4%)
|
176.06
est: 42.69 (+312.4%)
|
186.41
est: 71.01 (+162.5%)
|
69.70
69.70 – 69.70
-1.8% YoY
|
75.87
75.87 – 75.87
+8.9% YoY
|
69.57
69.57 – 69.57
-8.3% YoY
|
78.21
78.21 – 78.21
+12.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Anurag Roy | MD, President & Additional Director | 40M | male |
| Ashutosh Bhalchandra Kulkarni | Company Secretary, Compliance Officer & Head of Legal | — | male |
| Bhar Bhosale | Head of Human Resources | — | female |
| Devendra Jadhav | Head of Sales & Business Development, EL-2 & EC | — | male |
| L. Prabhune | Head of Engineering & Maintenance - Pimpri | — | male |
| Meenu Vijay | Vice President of Market & Technology Development | — | — |
| Sanjay Kulkarni | Chief Financial Officer and Vice President of Information Technology & Procurement | — | male |
| Saurabh Kishor Kothade | Head of Finance & Accounts | — | male |
| Abhiroop Upadhyay | Head of Sales, Wire Enamels & Construction Chemicals | — | male |
| Sunilkumar Patel | Head Projects - Ankleshawar | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ELANTAS.BO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
